Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models
about
Microenvironmental Targets in SarcomaResults of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.Patient-derived xenograft models in musculoskeletal malignancies.Recurrent paratesticular dedifferentiated liposarcoma after contralateral radical orchiectomy.Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.Dedifferentiated liposarcoma of the oral floor: A case study and literature review of 50 cases of head and neck neoplasm.
P2860
Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pazopanib, a Receptor Tyrosine ...... d Liposarcoma Xenograft Models
@ast
Pazopanib, a Receptor Tyrosine ...... d Liposarcoma Xenograft Models
@en
type
label
Pazopanib, a Receptor Tyrosine ...... d Liposarcoma Xenograft Models
@ast
Pazopanib, a Receptor Tyrosine ...... d Liposarcoma Xenograft Models
@en
prefLabel
Pazopanib, a Receptor Tyrosine ...... d Liposarcoma Xenograft Models
@ast
Pazopanib, a Receptor Tyrosine ...... d Liposarcoma Xenograft Models
@en
P2093
P2860
P50
P1476
Pazopanib, a Receptor Tyrosine ...... d Liposarcoma Xenograft Models
@en
P2093
Agnieszka Wozniak
Daphne Hompes
Jasmien Cornillie
Marguerite Stas
Thomas Van Looy
Ulla Vanleeuw
P2860
P304
P356
10.1016/J.TRANON.2014.09.007
P577
2014-12-01T00:00:00Z